Preview

Drug development & registration

Advanced search
Fullscreen

For citations:


Nikolaeva E.Yu., Shchetinina Yu.R., Shokhin I.E., Zverev V.V., Svitich O.A., Susova O.Yu., Mitrofanov A.A., Ammour Yu.I. Measles Virus as a Vector Platform for Glioblastoma Immunotherapy (Review). Drug development & registration. 2022;11(1):51-58. https://doi.org/10.33380/2305-2066-2022-11-1-51-58



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2305-2066 (Print)
ISSN 2658-5049 (Online)